Sign in
4

Changes in Ownership

CRISPR Therapeutics AG Filed Acc 0000899243-18-000520

Chief Legal Officer sold 38,000 shares at an average $21.64 ($822,500)

  • Chief Legal Officer acquired 8,000 shares (option exercise)

From the SEC's structured data for this filing

Trades in this filing

Dylan-Hyde Tyler · Chief Legal Officer

Table I: Non-derivative

3 lines
Date Transaction Shares Price Value Owned after D/I
2018-01-02 Sale : show line 1 in the form −30,000 $20.55 $616,500 70,204 D
2018-01-02 Exercise or conversion : show line 2 in the form +8,000 $12.57 $100,560 78,204 D
2018-01-02 Sale : show line 3 in the form −8,000 $25.75 $206,000 70,204 D
Open-market sales · 38,000 sh · avg $21.64 · $822,500

Table II: Derivative

2 lines
Date Transaction Shares Owned after D/I
2018-01-02 Exercise or conversion : show line 4 in the form Stock Option (Right to Buy) −6,490 37,773 D
2018-01-02 Exercise or conversion : show line 5 in the form Stock Option (Right to Buy) −1,510 25,157 D
Loading xslF345X03/doc4.xml…